Ads
related to: keytruda cancer drug- Treatment For BTCs
Is A Treatment An Option For
Your Patients With BTCs? View Study
- Clinical Study About BTCs
See Trial Data For A Therapy
For Biliary Tract Cancers.
- Request A Representative
Have Questions? Connect With A Rep
To Get The Answers You Need.
- Discover The Data
See Efficacy & Safety Data For A
Treatment For Biliary Tract Cancers
- Official Physician Site
Treatment Option For Biliary
Tract Cancers. Learn More Here.
- Dosing & Administration
View Dosing Regimen For A
Therapy For Biliary Tract Cancers.
- Treatment For BTCs
Search results
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
FOX 23 News Albany· 7 days agoEisai announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American Society of Clinical Oncology ...
Clean Energy Ventures closes second funding round - The Boston Globe
The Boston Globe· 6 hours agoChief executive Lauren Hobart has been expanding a new retail concept by renovating or relocating...
Why Top 4% Biotech Stock, Merus, Just Catapulted To A Record High
Investor's Business Daily· 5 days agoMerus stock catapulted to a record high Friday after its experimental regimen for head-and-neck ...
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
AOL· 1 day agoMerck did not immediately respond to Reuters' request for a comment, while Eyebiotech declined to comment. Eyebiotech is a clinical stage opthalmology company, with operations in the U.S. and ...
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
CBS 47 Fresno· 5 days agoUSA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the latest in cancer treatment ...
Hedge Funds Are Loading Up On This Dividend Stock
Benzinga via Yahoo Finance· 2 days agoThe markets are adjusting to the high interest rates environment, with all the major US stock indices reporting strong gains in May 2024. However, even...
Merus (MRUS) Surges 36% on Head & Neck Cancer Antibody Data
Zacks via Yahoo Finance· 2 days agoData from an earlier cut-off date shows that treatment with Merus' (MRUS) combination therapy...
ASCO: Early peek at Merus' bispecific cancer data lives up to investors' expectations
FierceBiotech· 6 days agoAnalysts have hailed Merus’ latest data drop in head and neck cancer as meeting investors’...
Merus Shares Surge 36% On Early Data of Potential Head, Neck Cancer Treatment
Market Watch· 5 days agoShares of Merus surged higher Friday after the company's head and neck cancer treatment candidate showed a reduction in the disease in 60% of evaluable patients in an early ...
Billionaire Ken Griffin Is Buying These Dividend Stocks Hand Over Fist. Should You?
Motley Fool via Yahoo Finance· 6 days agoThe company picked up new U.S. and European approvals for blockbuster drug Keytruda. It announced...
Ads
related to: keytruda cancer drug